Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Simeon George


  • Director at Crispr Therapeutics Ag (CRSP), 2019-06-13
  • Large Shareholder, Director at Principia Biopharma Inc. (PRNB), 2019-06-11
  • Director at Turning Point Therapeutics Inc. (TPTX), 2019-04-24
  • Director at Htg Molecular Diagnostics Inc (HTGM), 2015-05-05
  • Director at Genocea Biosciences Inc. (GNCA), 2014-02-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TPTX $18.00 325,000 Director 1,992,550 2019-04-22 Filing
PRNB $17.00 270,000 Large Shareholder, Director 2,625,713 2018-09-18 Filing
CRSP $14.00 66,500 Director 3,220,627 2016-10-24 Filing
GNCA $12.00 143,773 Director 143,773 2014-02-10 Filing